Effects On The SideRemdesivir: Miracle Cure or Deadly Gamble?
🚨 Once hailed as a beacon of hope against COVID-19, Remdesivir's past and present tell a more troubling story. In this episode of Effects on the Side, we delve into: The drug's alarming 53% mortality rate in Ebola trials. Its rapid endorsement during the pandemic despite questionable efficacy. Investigations into financial ties influencing its promotion. The ethical implications of prioritizing profit over patient safety. 🔎 Join us as we uncover the complex web behind Remdesivir and what it means for future medical interventions. 🎙️ Listen now on Effects on the Side.
Chapters (7)
- The Controversy Surrounding Remdesivir
- Remdesivir's Origins and the 2018-2019 Ebola Trials
- The Push for Remdesivir During the COVID-19 Pandemic
- Investigating Financial Ties and Conflicts of Interest
- Ethical Considerations and Public Trust
- Alternative Treatments and the Suppression of Options
- Lessons Learned and Moving Forward
About the podcast
Ever watched a pharmaceutical commercial and wondered, Are the side effects really worth it? Welcome to Effects on the Side, the podcast that takes a deep dive into the world of prescription drug commercials in the USA. Tune in, and let’s uncover the real story behind the side effects.
© 2025 All rights reserved.